Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group

International Journal of Cardiology

Volumn 201, Issue , 2015, Pages 684-691

  Burzotta, Francesco ^a   Trani, Carlo ^a   Doshi, Sagar N ^b   Townend, Jonathan ^b   Van Geuns, Robert Jan ^c   Hunziker, Patrick ^d   Schieffer, Bernhard ^d   Karatolios, Konstantinos ^d   Møller, Jacob Eifer ^d   Ribichini, Flavio L ^d   Schäfer, Andreas ^e   Henriques, José P S ^f  

^a CATHOLIC UNIVERSITY   (Italy)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF VERONA   (Italy)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Acute myocardial infarction; Cardiogenic shock; Expert group; High risk PCI; Impella; Mechanical support

Indexed keywords

ACCESS SITE BLEEDING; ANTICOAGULANT THERAPY; BLEEDING; CARDIOGENIC SHOCK; CATHETER; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL PROTOCOL; COOPERATION; CORONARY ARTERY BYPASS GRAFT; DEVICE INFECTION; DEVICE SAFETY; EQUIPMENT DESIGN; EUROPE; HEART AFTERLOAD; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE TENSION; HEART OUTPUT; HEMOLYSIS; HIGH RISK PATIENT; IMPELLA VENTRICULAR SUPPORT; INTRAAORTIC BALLOON PUMP; LIMB ISCHEMIA; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT SELECTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; VENTRICULAR ASSIST DEVICE; HEART ASSIST DEVICE; HEMODYNAMICS; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; SHOCK, CARDIOGENIC;

EQUIPMENT DESIGN; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; SHOCK, CARDIOGENIC;

EID: 84943519645     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.07.065     Document Type: Review

References (43)

1. K.D. Sjauw, A.E. Engstrom, M.M. Vis, R.J. van der Schaaf, J. Baan Jr., K.T. Koch, and et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur. Heart J. 30 2009 459 468
2. M.R. Patel, R.W. Smalling, H. Thiele, H.X. Barnhart, Y. Zhou, P. Chandra, and et al. Intra-aortic balloon counterpulsation and infarct size in patients with acute anterior myocardial infarction without shock: the CRISP AMI randomized trial JAMA 306 2011 1329 1337
3. H. Thiele, U. Zeymer, F.J. Neumann, M. Ferenc, H.G. Olbrich, J. Hausleiter, and et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock N. Engl. J. Med. 367 2012 1287 1296
4. L.D. Sauren, R.E. Accord, K. Hamzeh, M. de Jong, T. van der Nagel, F.H. van der Veen, and et al. Combined Impella and intra-aortic balloon pump support to improve both ventricular unloading and coronary blood flow for myocardial recovery: an experimental study Artif. Organs 31 2007 839 842
5. S.R. Dixon, J.P. Henriques, L. Mauri, K. Sjauw, A. Civitello, B. Kar, and et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience JACC Cardiovasc. Interv. 2 2009 91 96
6. M. Remmelink, K.D. Sjauw, J.P. Henriques, R.J. de Winter, K.T. Koch, R.J. van der Schaaf, and et al. Effects of left ventricular unloading by Impella recover LP2.5 on coronary hemodynamics Catheter. Cardiovasc. Interv. 70 2007 532 537
7. W.W. O'Neill, N.S. Kleiman, J. Moses, J.P. Henriques, S. Dixon, J. Massaro, and et al. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study Circulation 126 2012 1717 1727
8. G.D. Dangas, A.S. Kini, S.K. Sharma, J.P. Henriques, B.E. Claessen, S.R. Dixon, and et al. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial) Am. J. Cardiol. 113 2014 222 228
9. B. Maini, D. Gregory, D.J. Scotti, and L. Buyantseva Percutaneous cardiac assist devices compared with surgical hemodynamic support alternatives: cost-effectiveness in the emergent setting Catheter. Cardiovasc. Interv. 83 2014 E183 E192
10. J.B. Roos, S.N. Doshi, T. Konorza, I. Palacios, T. Schreiber, O.V. Borisenko, and et al. The cost-effectiveness of a new percutaneous ventricular assist device for high-risk PCI patients: mid-stage evaluation from the European perspective J. Med. Econ. 16 2013 381 390
11. W.W. O'Neill, T. Schreiber, D.H. Wohns, C. Rihal, S.S. Naidu, A.B. Civitello, and et al. The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry J. Interv. Cardiol. 27 2014 1 11
12. B.P. Griffith, M.B. Anderson, L.E. Samuels, W.E. Pae Jr., Y. Naka, and O.H. Frazier The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support J. Thorac. Cardiovasc. Surg. 145 2013 548 554
13. A. Lemaire, M.B. Anderson, L.Y. Lee, P. Scholz, T. Prendergast, A. Goodman, and et al. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock Ann. Thorac. Surg. 97 2014 133 138
14. A. Lauten, A.E. Engstrom, C. Jung, K. Empen, P. Erne, S. Cook, and et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry Circ. Heart Fail. 6 2013 23 30
15. A.E. Engstrom, R. Cocchieri, A.H. Driessen, K.D. Sjauw, M.M. Vis, J. Baan, and et al. The Impella 2.5 and 5.0 devices for ST-elevation myocardial infarction patients presenting with severe and profound cardiogenic shock: the Academic Medical Center intensive care unit experience Crit. Care Med. 39 2011 2072 2079
16. D. De Backer, P. Biston, J. Devriendt, C. Madl, D. Chochrad, C. Aldecoa, and et al. Comparison of dopamine and norepinephrine in the treatment of shock N. Engl. J. Med. 362 2010 779 789
17. R. Fincke, J.S. Hochman, A.M. Lowe, V. Menon, J.N. Slater, J.G. Webb, and et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry J. Am. Coll. Cardiol. 44 2004 340 348
18. H. Suradi, and J.A. Breall Successful use of the Impella device in giant cell myocarditis as a bridge to permanent left ventricular mechanical support Tex. Heart Inst. J. 38 2011 437 440
19. A.E. Engstrom, H. Granfeldt, W. Seybold-Epting, M. Dahm, R. Cocchieri, A.H. Driessen, and et al. Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience Minerva Cardioangiol. 61 2013 539 546
20. C.A. Martinez, V. Singh, J.C. Londono, M.G. Cohen, C.E. Alfonso, W.W. O'Neill, and et al. Percutaneous retrograde left ventricular assist support for interventions in patients with aortic stenosis and left ventricular dysfunction Catheter. Cardiovasc. Interv. 80 2012 1201 1209
21. J.C. Londono, C.A. Martinez, V. Singh, and W.W. O'Neill Hemodynamic support with impella 2.5 during balloon aortic valvuloplasty in a high-risk patient J. Interv. Cardiol. 24 2011 193 197
22. D.J. Ludeman, B.G. Schwartz, and S. Burstein Impella-assisted balloon aortic valvuloplasty J. Invasive Cardiol. 24 2012 E19 E20
23. J. Spiro, V. Venugopal, Y. Raja, P.F. Ludman, J.N. Townend, and S.N. Doshi Feasibility and efficacy of the 2.5 L and 3.8 L Impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis Catheter. Cardiovasc. Interv. 85 2015 981 989
24. C.A. Martinez, V. Singh, A.W. Heldman, and W.W. O'Neill Emergent use of retrograde left ventricular support in patients after transcatheter aortic valve replacement Catheter. Cardiovasc. Interv. 82 2013 E128 E132
25. Y.M. Reddy, L. Chinitz, M. Mansour, T.J. Bunch, S. Mahapatra, V. Swarup, and et al. Percutaneous left ventricular assist devices in ventricular tachycardia ablation: multicenter experience Circ. Arrhythm. Electrophysiol. 7 2014 244 250
26. H. Abuissa, J. Roshan, B. Lim, and S.J. Asirvatham Use of the Impella microaxial blood pump for ablation of hemodynamically unstable ventricular tachycardia J. Cardiovasc. Electrophysiol. 21 2010 458 461
27. F. Lu, P.M. Eckman, K.K. Liao, I. Apostolidou, R. John, T. Chen, and et al. Catheter ablation of hemodynamically unstable ventricular tachycardia with mechanical circulatory support Int. J. Cardiol. 168 2013 3859 3865
28. M.A. Miller, S.R. Dukkipati, A.J. Mittnacht, J.S. Chinitz, L. Belliveau, J.S. Koruth, and et al. Activation and entrainment mapping of hemodynamically unstable ventricular tachycardia using a percutaneous left ventricular assist device J. Am. Coll. Cardiol. 58 2011 1363 1371
29. M.A. Miller, S.R. Dukkipati, J.S. Chinitz, J.S. Koruth, A.J. Mittnacht, C. Napolitano, and et al. Percutaneous hemodynamic support with Impella 2.5 during scar-related ventricular tachycardia ablation (PERMIT 1) Circ. Arrhythm. Electrophysiol. 6 2013 151 159
30. S.V. Chaparro, A. Badheka, G.R. Marzouka, T. Tanawuttiwat, F. Ahmed, V. Sacher, and et al. Combined use of Impella left ventricular assist device and extracorporeal membrane oxygenation as a bridge to recovery in fulminant myocarditis ASAIO J. 58 2012 285 287
31. H. Suradi, and J.A. Breall Successful use of the Impella device in giant cell myocarditis as a bridge to permanent left ventricular mechanical support Tex. Heart Inst. J. 38 2011 437 440
32. L.A. Zornoff, H. Skali, M.A. Pfeffer, M. St John Sutton, J.L. Rouleau, G.A. Lamas, and et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction J. Am. Coll. Cardiol. 39 2002 1450 1455
33. M.S. Koeckert, U.P. Jorde, Y. Naka, J.W. Moses, and H. Takayama Impella LP 2.5 for left ventricular unloading during venoarterial extracorporeal membrane oxygenation support J. Card. Surg. 26 2011 666 668
34. A. Cheng, M.F. Swartz, and H.T. Massey Impella to unload the left ventricle during peripheral extracorporeal membrane oxygenation ASAIO J. 59 2013 533 536
35. D. Kawashima, S. Gojo, T. Nishimura, Y. Itoda, K. Kitahori, N. Motomura, and et al. Left ventricular mechanical support with Impella provides more ventricular unloading in heart failure than extracorporeal membrane oxygenation ASAIO J. 57 2011 169 176
36. A.W. Cheung, C.W. White, M.K. Davis, and D.H. Freed Short-term mechanical circulatory support for recovery from acute right ventricular failure: clinical outcomes J. Heart Lung Transplant. 33 2014 794 799
37. P. Hunziker, and L. Hunziker Percutaneous biventricular cardiac assist device in cardiogenic shock Eur. Heart J. 34 2013 1620
38. R.J. Cubeddu, R. Lago, S.A. Horvath, P.A. Vignola, W. O'Neill, and I.F. Palacios Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature Eurointervention 7 2012 1453 1460
39. D.M. Wiktor, N. Sawlani, Y. Kanthi, I. Sipahi, J.C. Fang, and A. Blitz Successful combined use of Impella Recover 2.5 device and intra-aortic balloon pump support in cardiogenic shock from acute myocardial infarction ASAIO J. 56 2010 519 521
40. B.J. Doyle, H.H. Ting, M.R. Bell, R.J. Lennon, V. Mathew, M. Singh, and et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005 JACC Cardiovasc. Interv. 1 2008 202 209
41. F. Burzotta, L. Paloscia, C. Trani, M. Mascellanti, R. Mongiardo, G. Materazzo, and et al. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study J. Cardiovasc. Med. (Hagerstown) 9 2008 1004 1010
42. J.P. Henriques, M. Remmelink, J. Baan Jr., R.J. van der Schaaf, M.M. Vis, K.T. Koch, and et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5 Am. J. Cardiol. 97 2006 990 992
43. J.P. Henriques, D.M. Ouweneel, S.S. Naidu, I.F. Palacios, J. Popma, E.M. Ohman, and et al. Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study Am. Heart J. 167 2014 472 479 e5